Skip to main content

and
  1. Article

    Open Access

    Public information needs and preferences on COVID-19: a cross-sectional study

    Right from the beginning of the SARS-CoV-2 pandemic the general public faced the challenge to find reliable and understandable information in the overwhelming flood of information. To enhance informed decision...

    Julia Lühnen, Thomas Frese, Wilfried Mau, Gabriele Meyer in BMC Public Health (2023)

  2. Article

    Open Access

    Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation

    Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance data revealed low ICU survival rates. Patient charac...

    Johannes Herrmann, Christopher Lotz, Christian Karagiannidis in Critical Care (2022)

  3. Article

    Open Access

    COVID-19-Pandemie: Präferenzen und Barrieren für die Disseminierung von Evidenzsynthesen

    Das COVID-19-Evidenz-Ökosystem (CEOsys) identifiziert, bewertet und fasst Ergebnisse wissenschaftlicher Studien in Evidenzsynthesen im Kontext von COVID-19 zusammen. Diese Evidenzsynthesen werden genutzt, um k...

    Dr. med. Christian Seeber, Maria Popp, Joerg J. Meerpohl, Falk Fichtner in Der Anaesthesist (2022)

  4. Article

    Open Access

    Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients

    Jakob J. Malin, Christoph D. Spinner, Uwe Janssens, Tobias Welte in Infection (2022)

  5. Article

    Open Access

    Key summary of German national treatment guidance for hospitalized COVID-19 patients

    This executive summary of a national living guideline aims to provide rapid evidence based recommendations on the role of drug interventions in the treatment of hospitalized patients with COVID-19.

    Jakob J. Malin, Christoph D. Spinner, Uwe Janssens, Tobias Welte in Infection (2022)

  6. Article

    Open Access

    Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort

    Intensive Care Resources are heavily utilized during the COVID-19 pandemic. However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon ICU admission remain inadequate. This study ...

    Harry Magunia, Simone Lederer, Raphael Verbuecheln, Bryant Joseph Gilot in Critical Care (2021)

  7. Article

    Open Access

    Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial

    Albumin is a key regulator of fluid distribution within the extracellular space and has several properties beyond its oncotic activity. The accumulating evidence suggests that supplementation of albumin may pr...

    Yasser Sakr, Michael Bauer, Axel Nierhaus, Stefan Kluge, Ulricke Schumacher in Trials (2020)